KUALA LUMPUR: Duopharma Biotech Bhd (formerly CCM Duopharma Biotech Bhd
) posted net profit of RM55.27mil in the financial year ended Dec 31,2019 and was upbeat on its outlook for its pharmaceutical products due to the extension of contract periods by the government.
In a filing with the exchange, the company said yesterday its net profit had increased by 16% from RM47.64mil in FY18. Its revenue rose by 15.6% to RM576.46mil from RM498.72mil.
In the fourth quarter, its net profit slipped by 16.2% to RM 12.03mil from RM14.37mil. Its revenue increased to RM137.75mil from RM155.63mil. EPS were 1.76 compared with 2.17 sen.
...